JN.1 and other new coronavirus strains: Three things to know
SARS-CoV-2, the virus that causes COVID-19, has continued to mutate and spread. Yale experts tell you what you need to know. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 21, 2023 Category: Universities & Medical Training Source Type: news
SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals
CDC reviewed COVID-19 rebound studies among patients who did and did not receive antiviral treatment. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - December 21, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials - United States and International Sites, 2021-2022
This report describes data from two randomized, double-blind clinical trials that investigated COVID-19 rebound following treatment with or without nirmatrelvir/ritonavir. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - December 21, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization
Guidance for Industry (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 20, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Is this the smoking gun for the Covid lab leak? Blueprint for creating a 'SARS-CoV' virus with an altered spike protein in Wuhan was published in 2018, bombshell new records show
A newly-uncovered trove of documents detailing plans to create a Covid-like virus in China months before the pandemic make the 'lab leak almost certain', experts say. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2023 Category: Consumer Health News Source Type: news
'Repeated infections of Covid certainly not good for health'
Indian SARS-CoV-2 Genomics Consortium (Insacog), the network of laboratories set up to monitor genomic variations of the coronavirus, also decided to hold a meeting on Wednesday after the minister's meeting. It was earlier supposed to be held on Friday. "We will discuss the current status of Covid in the country, review of sewage surveillance and the hospital network," said an Insacog member. (Source: The Economic Times)
Source: The Economic Times - December 19, 2023 Category: Consumer Health News Source Type: news
What to Know About the JN.1 Variant of the COVID-19 Virus
A new variant of the virus that causes COVID-19 is rising to prominence in the U.S. as winter illness season approaches its peak: JN.1, yet another descendent of Omicron.
JN.1 was first detected in the U.S. in September but spread slowly at first. In recent weeks, however, it has accounted for a growing percentage of test samples sequenced by labs affiliated with the U.S. Centers for Disease Control and Prevention (CDC), surpassing 20% during the two-week period ending Dec. 9. By some projections, it will be responsible for at least half of new infections in the U.S. before December ends.
[time-brightcove not-tgx=”...
Source: TIME: Health - December 18, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Science ’s 2023 Breakthrough of the Year: Weight loss drugs with a real shot at fighting obesity
Show / hide sections navigation
2023 Breakthrough of the Year
Runners-up
Breakdowns
Video
Obesity plays out as a private struggle and a public health crisis. In the United States, about 70% of adults are affected by excess weight, and in Europe that number is more than half. The stigma against fat can be crushing; its risks, life-threatening. Defined as a body mass index of at least 30, obesity is thought to power type 2 diabetes, heart disease, arthritis, fatty liver disease, and certain cancers.
Yet drug treatments...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news
Impact of COVID-19 infections and vaccines on preterm birth
While contracting COVID-19 increased the risk of preterm birth between 2020 and 2022, the risk then faded, due in large part to SARS-CoV-2 vaccines. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - December 12, 2023 Category: Consumer Health News Source Type: news
Wide Regional Variation in Diagnosis of Long COVID Wide Regional Variation in Diagnosis of Long COVID
The percentage of patients with a U09.9 diagnostic code in the year after a SARS-CoV-2 infection ranged from less than 4% in one region to more than 24% in anotherMedscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2023 Category: Consumer Health News Tags: Internal Medicine Source Type: news
Navigating Epidemiological Uncertainty Navigating Epidemiological Uncertainty
Join Prof David Heymann as he addresses the complex epidemiological aspects of SARS-CoV-2, discussing the evolution of the virus and key developments in resolving the COVID-19 global health crisis.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 8, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Getting Sick All the Time? Don ’ t (Necessarily) Blame COVID-19
Respiratory disease season is in full swing, with influenza, RSV, and COVID-19 case counts rising in various parts of the U.S. Hospitals in some states are also reporting upticks in pediatric pneumonia diagnoses, which experts say seems to be unrelated to the recent spike of pneumonias reported in China.
On the heels of last year’s severe flu and RSV reason, all this contagion has some people wondering if SARS-CoV-2, the virus that causes COVID-19, may be to blame. Some studies suggest the virus leaves its mark on the immune system even after an acute illness passes, raising an important question: does having COVI...
Source: TIME: Health - December 7, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
The Updated COVID-19 Shot Works on the Newest Variants
Every COVID-19 vaccine is a step behind the virus. In the time it takes companies to make the shot, SARS-CoV-2 is already busy mutating into different versions that can evade the immune response produced by it.
But even though the latest vaccine targets XBB.1.5, a variant no longer dominant in the U.S., it seems to be doing a decent job at warding off some of the emerging variants. In a study published on the preprint server bioRxiv, scientists led by Dr. David Ho, director of the Aaron Diamond AIDS Research Center at Columbia University, report that the vaccine can generate strong antibodies that can neutralize not jus...
Source: TIME: Health - December 7, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
How to Get Free Flu and COVID-19 Tests and Treatments
As we head into winter, health experts expect that cases of flu and COVID-19 will start to creep up. One piece of good news: if you do get sick, there’s a way to get tests and treatments for both—without paying a cent.
The National Institutes of Health (NIH), the Administration for Strategic Preparedness and Response and the Centers for Disease Control and Prevention have teamed up with digital health company eMed to create an at-home test-to-treat program that offers free tests for both flu and COVID-19, and, if you are positive, free telehealth visits and antiviral treatments that are sent to your home.
[t...
Source: TIME: Health - December 6, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Substandard and falsified ivermectin tablets obtained for self-medication during the COVID-19 pandemic as a source of potential harm - Vanhee C, Jacobs B, Kamugisha A, Canfyn M, Van Der Meersch H, Ceyssens B, Deconinck E, Van Hoorde K, Willocx M.
In 2019, a global viral pandemic, due to the SARS-CoV-2 virus, broke out. Soon after, the search for a vaccine and/or antiviral medicine began. One of the candidate antiviral medicines tested was ivermectin. Although several health authorities warned the p... (Source: SafetyLit)
Source: SafetyLit - December 5, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
